The Medicines (Products for Human Use) (Fees) Regulations 2016
5 Capital Fees for Applications for Variations of Authorisations, Registrations and Licences and for Associate
- 19Fees for variations of authorisations, registrations and licences
- 19aFees for certification of plasma master files
- 19bFee for certification of vaccine antigen master files
- 19cFees for assessment of post-authorisation safety studies
- 19dFee for carrying out a major safety review
- 19eFee for assessment of periodic safety update reports
- 19eaFee for assessment of clinical trial annual safety reports
- 19fFee for testing of samples by the appropriate authority
- 19gTime for payment of fees under regulations 19A to 19F
- 20Fees for modifications to clinical trial authorisations
- 21Fees for notification of changes and reports for broker's registrations
- 22Fees for notification of changes and compliance Reports for active substance registrations
- 23Applications for multiple variations
Source: legislation.gov.uk (The National Archives), UK legislation with its point-in-time versions. Official publication. Reuse: Open Government Licence v3.0.